EFFICACY OF MEASLES-VACCINES AFTER CONTROLLING FOR EXPOSURE

被引:13
作者
GARENNE, M
LEROY, O
BEAU, JP
SENE, I
机构
[1] HARVARD UNIV, SCH PUBL HLTH, BOSTON, MA 02115 USA
[2] PASTEUR MERIEUX SERUMS & VACCINS, PARIS, FRANCE
[3] ORSTOM, INST FRANCAIS RECH SCI DEV COOPERAT, UNITE RECH POPULAT & SANTE, DAKAR, SENEGAMBIA
[4] CIRCONSCRIPT MED FATICK, FATICK, SENEGAMBIA
关键词
CHILD; MEASLES; MEASLES VACCINE; MULTIVARIATE ANALYSIS; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RURAL POPULATION;
D O I
10.1093/oxfordjournals.aje.a116844
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The clinical efficacy of measles vaccines was investigated in Niakhar, a rural area of Senegal under demographic surveillance in 1987-1990. Three measles vaccines were tested: a standard Schwarz, a high-titer Edmonston-Zagreb, and a high-titer Schwarz. The two high-titer vaccines were administered at 5 months of age and the standard Schwarz vaccine at 10 months. In addition to a formal randomized vaccine trial, data from national campaigns using the standard Schwarz vaccine were also analyzed. Clinical efficacy was estimated after controlling for exposure. In the randomized trial, the estimate of the efficacy of the standard Schwarz vaccine was 97.2% (95% confidence interval (CI) 91.3-98.1). In the 1986-1987 national campaign, the efficacy of the standard Schwarz vaccine was lower: 92.5% (95% CI 88.8-94.6). In the randomized trial, the efficacy of the high-titer vaccines was lower than that of the standard vaccine. High-titer vaccines were not used in national campaigns. Other factors associated with vaccine efficacy were age at exposure, intensity of exposure, and age at vaccination. Controlling for the intensity of exposure did not change the relative ranking of the efficacy of the three vaccination strategies. The theoretical efficacy of the standard measles vaccine for a single unit of exposure was estimated at 98.0%.
引用
收藏
页码:182 / 195
页数:14
相关论文
共 31 条
[1]  
[Anonymous], 1975, MATH THEORY INFECT D
[2]  
[Anonymous], 1992, WKLY EPIDEMIOL REC, V67, P357
[3]  
COULIBALY A, 1990, ACTUALITES MED, P599
[4]   FIELD-EVALUATION OF MEASLES-VACCINE EFFICACY IN MOZAMBIQUE [J].
CUTTS, FT ;
SMITH, PG ;
COLOMBO, S ;
MANN, G ;
ASCHERIO, A ;
SOARES, AC .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1990, 131 (02) :349-355
[5]   A PERSISTENT OUTBREAK OF MEASLES DESPITE APPROPRIATE PREVENTION AND CONTROL MEASURES [J].
DAVIS, RM ;
WHITMAN, ED ;
ORENSTEIN, WA ;
PREBLUD, SR ;
MARKOWITZ, LE ;
HINMAN, AR .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1987, 126 (03) :438-449
[6]   CHILD-MORTALITY AFTER HIGH-TITER MEASLES-VACCINES - PROSPECTIVE-STUDY IN SENEGAL [J].
GARENNE, M ;
LEROY, O ;
BEAU, JP ;
SENE, I .
LANCET, 1991, 338 (8772) :903-907
[7]   PATTERN OF EXPOSURE AND MEASLES MORTALITY IN SENEGAL [J].
GARENNE, M ;
AABY, P .
JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (06) :1088-1094
[8]  
GARENNE M, 1986, ESTIMATION MORTALITE, V145, P515
[9]  
GARENNE M, IN PRESS ARCH VIROL
[10]  
GARENNE M, 1991, EFFICACY SAFETY IMMU